Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,512 | -3,408 | -11,428 | -6,416 | -2,882 |
| Depreciation Amortization | 278 | 135 | 297 | 178 | 75 |
| Accounts receivable | -2,102 | 499 | 311 | 484 | -95 |
| Accounts payable and accrued liabilities | 2,317 | 308 | 725 | 322 | -164 |
| Other Working Capital | -1,349 | -1,221 | -1,488 | -3,203 | -4,271 |
| Other Operating Activity | 668 | -356 | 1,109 | 659 | 1,232 |
| Operating Cash Flow | $-8,700 | $-4,043 | $-10,473 | $-7,977 | $-6,104 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,000 | N/A | 12,000 | 9,000 | 6,000 |
| PPE Investments | -1,808 | -764 | -3,257 | -2,426 | -311 |
| Purchase Of Investment | -9,118 | -9,118 | -30,166 | -15,077 | -6,034 |
| Purchase Sale Intangibles | -90 | -38 | -245 | -284 | -141 |
| Other Investing Activity | -90 | -38 | -245 | -284 | -141 |
| Investing Cash Flow | $-8,016 | $-9,920 | $-21,668 | $-8,787 | $-486 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 646 | 103 | 64,908 | 9,602 | 5,267 |
| Other Financing Activity | -104 | -104 | -29 | -29 | -29 |
| Financing Cash Flow | $541 | $-1 | $64,879 | $9,573 | $5,238 |
| Exchange Rate Effect | -8 | -7 | 1 | -8 | -33 |
| Beginning Cash Position | 52,097 | 52,097 | 19,358 | 19,358 | 19,358 |
| End Cash Position | 35,915 | 38,126 | 52,097 | 12,160 | 17,973 |
| Net Cash Flow | $-16,182 | $-13,971 | $32,739 | $-7,198 | $-1,385 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,700 | -4,043 | -10,473 | -7,977 | -6,104 |
| Capital Expenditure | -1,808 | -764 | -3,257 | -2,426 | -311 |
| Free Cash Flow | -10,508 | -4,807 | -13,730 | -10,402 | -6,414 |